Recombinant human erythropoietin (rHuEPO) therapy in patients with cancer-related anaemia: what have we learned?
Osterborg
A
A
Department of Oncology (Radiumhemmet), Karolinska Hospital, Stockholm, Sweden.
D000740:Anemia / Q000188:drug therapy* / Q000209:etiology*; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D011788:Quality of Life; D011994:Recombinant Proteins
D011994:Recombinant Proteins; D004921:Erythropoietin